Bank of New York Mellon’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7K | Sell |
|
|||||
|
2025
Q1 | $119K | Hold |
|
|||||
|
2024
Q4 | $495K | Sell |
|
|||||
|
2024
Q3 | $703K | Sell |
|
|||||
|
2024
Q2 | $910K | Buy |
|
|||||
|
2024
Q1 | $1.7M | Sell |
|
|||||
|
2023
Q4 | $897K | Buy |
|
|||||
|
2023
Q3 | $477K | Sell |
|
|||||
|
2023
Q2 | $1.24M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Buy |
|
|||||
|
2022
Q4 | $2.16M | Buy |
|
|||||
|
2022
Q3 | $2.44M | Buy |
|
|||||
|
2022
Q2 | $1.59M | Buy |
|
|||||
|
2022
Q1 | $1.13M | Buy |
|
|||||
|
2021
Q4 | $1.74M | Buy |
|
|||||
|
2021
Q3 | $2.55M | Buy |
|
|||||
|
2021
Q2 | $3.38M | Sell |
|
|||||
|
2021
Q1 | $4.23M | Sell |
|
|||||
|
2020
Q4 | $7.36M | Sell |
|
|||||
|
2020
Q3 | $5.18M | Buy |
|
|||||
|
2020
Q2 | $6.35M | Buy |
|
|||||
|
2020
Q1 | $1.14M | Buy |
|
|||||
|
2019
Q4 | $1.11M | Buy |
|
|||||
|
2019
Q3 | $160K | Sell |
|
|||||
|
2019
Q2 | $434K | Buy |
|
|||||
|
2019
Q1 | $204K | Sell |
|
|||||
|
2018
Q4 | $160K | Buy |
|
|||||
|
2018
Q3 | $329K | Buy |
|
|||||
|
2018
Q2 | $564K | Buy |
|
|||||
|
2018
Q1 | $392K | Buy |
|
|||||
|
2017
Q4 | $254K | Buy |
|
|||||
|
2017
Q3 | $231K | Buy |
|